Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients
Official title: Body Surface Gastric Mapping in Patients With Dyspeptic Symptoms: Recordings at Baseline and on Medical Therapy
Run by University of Auckland, New Zealand · NCT06854120 · Data updated 2026-11-12
This study tests whether using Body Surface Gastric Mapping can help predict which medications will help people with gastroparesis or functional dyspepsia see improvement.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 125 (estimated) |
| Sponsor | University of Auckland, New Zealand Academic / other |
| Locations | 3 sites (Philadelphia, Pennsylvania and 2 other locations) |
| Status | Recruiting |
| Started | February 26, 2025 |
| Main results expected | February 26, 2028 |
| Study ends | August 26, 2028 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT06854120 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with gastroparesis or functional dyspepsia who are being prescribed a prokinetic or a symptom-modulating agent and can undergo two BSGM recordings.
✕Probably not a fit
Patients who do not show a correlation between BSGM patterns and symptom changes, or who do not respond to the prescribed therapy, may not experience a benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses the Gastric Alimetry body surface mapping device to record gastric myoelectrical activity before and after starting a prokinetic or symptom-modulating therapy in adults with gastroparesis or functional dyspepsia. Researchers aim to identify baseline mapping features that may forecast which patients will respond to treatment. The study collects two non-invasive recordings and correlates them with changes in symptoms to guide personalized therapy choices. It is conducted at sites in Auckland, Philadelphia, and Sydney with collaboration across multiple institutions. No experimental therapies are introduced beyond standard clinical care plus the BSGM assessment.
Why it matters
Potential benefit: If successful, patients could receive more tailored treatments based on their gastric electrical patterns, potentially improving symptom relief.
How similar studies have gone: Previous work with gastric motility testing and mapping has shown potential, but this approach is exploratory for predicting individual treatment response.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years of age and older * Diagnosis of gastroparesis and/or functional dyspepsia * Being prescribed a prokinetic agent or symptom modulator for their clinical care * Able to undergo BSGM recording both before and during treatment * Able to give informed consent for undergoing a baseline BSGM recording and an additional recording while on treatment Exclusion Criteria: * Under 18 years of age * Prior surgery on esophagus, stomach (appendectomy and cholecystectomy are allowed) * History of skin allergies or a history of extreme sensitivity to cosmetics or lotions * Pregnant women * No vulnerable groups such as prisoners, individuals with known cognitive impairment, or institutionalized individuals be involved
Where it's running
-
Western Sydney University
Sydney, New South Wales, Australia Recruiting -
Te Whatu Ora Waitemata
Auckland, Auckland, New Zealand Recruiting -
Temple University
Philadelphia, Pennsylvania, United States Not yet recruiting
Study contacts
- Principal investigator: Henry Parkman, MD — Temple University
- Study coordinator: Genevieve M Johnston, PhD
- Email: gen.johnston@auckland.ac.nz
- Phone: +64 9 373 7599
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing gastric functions in patients with diabetes
This study looks at how diabetes affects stomach function in people with Type 1 and Type 2 diabetes to see if there are any problems and how these issues relate to their overall health.
-
Low-FODMAP Diet vs Standard Dietary Advice for Functional Dyspepsia
This study tests whether a low-FODMAP diet helps adults with functional dyspepsia compared with standard dietary advice.
-
Gastric-focused ultrasound to see if it changes stomach activity and symptoms
This study tests whether noninvasive stomach-focused ultrasound can alter post-meal stomach electrical activity and symptoms in adults with gastroparesis or delayed gastric emptying, using a sham control in a crossover design.
-
Pain Reprocessing Therapy for Functional Dyspepsia
A small pilot test to see if a psychological therapy that uses exposure techniques can lessen digestive symptoms and help daily functioning in people with functional dyspepsia.
-
Gastric emptying and feeding tolerance in ICU patients by vasopressor dose
This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.
-
Identifying Signatures of Gut Interoception in Functional Dyspepsia and Anorexia Nervosa
This study tests how the gut-brain connection works in people with functional dyspepsia or anorexia nervosa using brain imaging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.